跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
戴 英軒
副教授
,
麻醉學科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0002-5210-6873
電子郵件
18045
s.tmu.edu
tw
h-index
1193
引文
17
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2026
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(104)
資料集
(1)
類似的個人檔案
(12)
指紋
查看啟用 Ying-Hsuan Tai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adverse Outcome
7%
Alopecia Areata
33%
Analgesia
8%
Atopic Dermatitis
8%
Autoimmune Skin Disease
10%
Blood Transfusion
10%
Body Mass Index
10%
Cancer Recurrence
14%
Cancer Surgery
27%
Cardiopulmonary Bypass
10%
Cigarette Smoking
7%
Cohort Analysis
100%
Colorectal Carcinoma
10%
Diseases
9%
Drug Megadose
8%
Dry Eye
12%
Epidural Analgesia
22%
Eye Disease
10%
Fatty Acid Desaturation
11%
General Anesthesia
10%
Glyceryl Trinitrate
10%
Hazard Ratio
51%
Heart Surgery
10%
Hepatocellular Carcinoma
14%
Inflammation
12%
Intravenous Patient-Controlled Analgesia
18%
Kidney Function
8%
Lymphocyte
10%
Major Depressive Episode
9%
Major Surgery
18%
Malignant Neoplasm
9%
Meta-Analysis
7%
Morphine
18%
Neuraxial Anesthesia
7%
Neutrophil
7%
Nitric Oxide
8%
Non Small Cell Lung Cancer
16%
Ocular Surface
7%
Odds Ratio
22%
Overall Survival
15%
Postoperative Complication
8%
Postoperative Pain
19%
Propensity Score Matching
10%
Proportional Hazards Model
11%
Randomized Controlled Trial
20%
Recurrent Disease
12%
Retrospective Cohort Study
15%
Sevoflurane
7%
Thorax Surgery
7%
Video-Assisted Thoracoscopic Surgery
9%
Nursing and Health Professions
Alopecia Areata
24%
Blood Transfusion
15%
Cancer Prognosis
5%
Cancer Recurrence
15%
Cancer Surgery
25%
Cigarette Filter
10%
Cohort Analysis
51%
Colorectal Carcinoma
14%
Confidence Interval
27%
Epidural Analgesia
17%
Hazard Ratio
20%
Liver Cancer
7%
Major Surgery
10%
Malignant Neoplasm
7%
Meta Analysis
7%
Non Small Cell Lung Cancer
12%
Odds Ratio
6%
Overall Survival
15%
Pain Intensity
6%
Patient Controlled Analgesia
8%
Perioperative
12%
Postoperative Pain
14%
Propensity Score
25%
Proportional Hazards Model
10%
Recurrence Free Survival
7%
Recurrent Disease
16%
Retina Disease
7%
